N-{5-bromoimidazo[1,2-a]pyridin-2-yl}cyclopropanecarboxamide, 97.0%, 500mg

8-Chloro-2-phenyl-3-((1S)-1-((9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-yl)amino)ethyl)isoquinolin-1(2H)-one, 98%, 250mg

m-Xylene>99.0%(GC)500mL

o-Toluoyl Chloride>98.0%(GC)(T)500g

1-tert-Butyl 4-methyl 3-oxopiperidine-1,4-dicarboxylate, 95.0%, 5g

4-Chloro-5,7-difluoroquinoline, 98+%, 250mg

(2,4-Dichloro-6-methylpyridin-3-yl)methanol, 97%, 250mg

1-Cyclopropyl-1,3-butanedione, 95.0%, 1g

2-Bromo-3-fluoro-6-methyl pyridine, 95.0%, 5g

Tetrahydro-2H-thiopyran-4-ol>98.0%(GC)1g

tert-Butyl (2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethyl)carbamate, 97%, 25g

4-Bromo-3-methylbenzaldehyde, 95.0%, 500g

ethyl 3-(dipropylamino)propanoate, 95.0%, 10g